Delphine Lequin

1.8k total citations · 1 hit paper
10 papers, 1.0k citations indexed

About

Delphine Lequin is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Delphine Lequin has authored 10 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 4 papers in Neurology. Recurrent topics in Delphine Lequin's work include Cancer Mechanisms and Therapy (4 papers), Chromatin Remodeling and Cancer (4 papers) and Neuroblastoma Research and Treatments (3 papers). Delphine Lequin is often cited by papers focused on Cancer Mechanisms and Therapy (4 papers), Chromatin Remodeling and Cancer (4 papers) and Neuroblastoma Research and Treatments (3 papers). Delphine Lequin collaborates with scholars based in France, Switzerland and Italy. Delphine Lequin's co-authors include Olivier Delattre, Isabelle Janoueix‐Lerosey, Gudrun Schleiermacher, Agnès Ribeiro, Gaëlle Pierron, Valérie Combaret, Dominique Valteau‐Couanet, Jean Michon, Stanislas Lyonnet and Thierry Frébourg and has published in prestigious journals such as Nature, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Delphine Lequin

10 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

2008 622 citations Isabelle Janoueix‐Lerosey, Delphine Lequin et al. Nature profile →

Peers

Countries citing papers authored by Delphine Lequin

Since Specialization

Citations

This map shows the geographic impact of Delphine Lequin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delphine Lequin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delphine Lequin more than expected).

Fields of papers citing papers by Delphine Lequin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delphine Lequin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delphine Lequin. The network helps show where Delphine Lequin may publish in the future.

Co-authorship network of co-authors of Delphine Lequin

This figure shows the co-authorship network connecting the top 25 collaborators of Delphine Lequin. A scholar is included among the top collaborators of Delphine Lequin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delphine Lequin. Delphine Lequin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Title	Journal	Authors	Indexed citations
1	Germline MBD4 Mutations and Predisposition to Uveal Melanoma	JNCI Journal of the National Cancer Institute	Manuel Rodrigues, Stéphane Dayot et al.	38
2	MBRS-47. RAPID MOLECULAR SUBGROUPING OF MEDULLOBLASTOMA BASED ON DNA METHYLATION BY NANOPORE SEQUENCING	Neuro-Oncology	Julien Masliah‐Planchon, Elodie Girard et al.	2
3	The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation	Nature Communications	Zhi‐Yan Han, Wilfrid Richer et al.	74
4	Rhabdoid Tumours of Brain, Liver, Kidney and Soft-Parts: Expression Profiles Suggest Common Features but Different Entities.	Cancer Genetics	Wilfrid Richer, Carlo Lucchesi et al.	1
5	SMARCB1 Deficiency in Tumors From the Peripheral Nervous System	The American Journal of Surgical Pathology	Daniela Rizzo, Paul Fréneaux et al.	26
6	Atypical teratoid rhabdoid tumor mimicking beta-catenin-positive nodular medulloblastoma	Acta Neuropathologica	Pascale Varlet, Ludovic Lacroix et al.	4
7	Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma	Journal of Clinical Oncology	Isabelle Janoueix‐Lerosey, Gudrun Schleiermacher et al.	232
8	Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma breakdown →	Nature	Isabelle Janoueix‐Lerosey, Delphine Lequin et al.	622
9	Characterization of amplicons in neuroblastoma: High‐resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes	Genes Chromosomes and Cancer	Carlo Lucchesi, Agnès Ribeiro et al.	37
10	Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary)	BMC Cancer	Delphine Lequin, Karim Fizazi et al.	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact